Long-term inhaled nitric oxide plus phosphodiesterase 5 inhibitors for severe pulmonary hypertension. [electronic resource]
Producer: 20090619Description: 1326-32 p. digitalISSN:- 1557-3117
- Administration, Inhalation
- Adult
- Aged
- Anticoagulants -- therapeutic use
- Cyclic GMP -- blood
- Cyclic Nucleotide Phosphodiesterases, Type 5 -- metabolism
- Diuretics -- therapeutic use
- Female
- Follow-Up Studies
- Humans
- Hypertension, Pulmonary -- complications
- Male
- Middle Aged
- Nitric Oxide -- administration & dosage
- Phosphodiesterase 5 Inhibitors
- Phosphodiesterase Inhibitors -- therapeutic use
- Safety
- Thromboembolism -- complications
- Treatment Outcome
- Vasodilator Agents -- therapeutic use
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.